Skip to main content
Clinical Trials/TCTR20220527003
TCTR20220527003
Recruiting
Phase 4

Effectiveness of Autologous Fibroblasts on Facial Rejuvenation

Research department, Faculty of Medicine Siriraj Hospital0 sites30 target enrollmentMay 27, 2022

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Research department, Faculty of Medicine Siriraj Hospital
Enrollment
30
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 27, 2022
End Date
December 21, 2022
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Research department, Faculty of Medicine Siriraj Hospital

Eligibility Criteria

Inclusion Criteria

  • patients who expressed dissatisfaction with their nasolabial folds and periorbital wrinkles based on a score of \-1 or \-2 on the Subject
  • Wrinkle Assessment Scale

Exclusion Criteria

  • : (1\) were pregnant or lactating; (2\) had a history of connective tissue disorder, skin cancers, or related
  • diseases; (3\) had previous autologous fibroblast treatment; (4\) had previous treatment with fillers, lasers or
  • energy\-based devices within the last 12 months; (5\) had previous treatment using transdermal drug delivery,
  • chemical peeling or topical retinoid within the last month; or (6\) had allergy to collagen, meat and dairy
  • products, gentamycin, amphotericin B, or related products.

Outcomes

Primary Outcomes

Not specified

Similar Trials